Medtelligence: Linking Science to Clinical Practice - Medtelligence

Medtelligence Hero

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

MinuteCE®
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP; Leonie Kraft, MD
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Leonie Kraft, MD
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 credit 9 episodes
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
MinuteCE®
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD; Federico Alberici, MD, PhD
1.00 credit 9 episodes
- Steven Fishbane, MD
- Federico Alberici, MD, PhD
- Nancy Helou, PhD
- Anastasia Liossatou, PhD, RN
1.00 credit 9 episodes
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits

Popular

Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
MinuteCE®
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Jonathan Barratt, MD, PhD; An De Vriese, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
- An De Vriese, MD, PhD
1.00 program credit
Navigating KDIGO Guidance in IgAN
Navigating KDIGO Guidance in IgAN
MinuteCE®
Navigating KDIGO Guidance in IgAN
Jonathan Barratt, MD, PhD; Jörg Latus, MD
1.00 program credit
- Jonathan Barratt, MD, PhD
- Jörg Latus, MD
1.00 program credit
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
MinuteCE®
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Jörg Latus, MD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- Jörg Latus, MD
1.00 program credit
Translating Evidence into IgAN Care
Translating Evidence into IgAN Care
MinuteCE®
Translating Evidence into IgAN Care
Jonathan Barratt, MD, PhD; Jörg Latus, MD
1.00 program credit
- Jonathan Barratt, MD, PhD
- Jörg Latus, MD
1.00 program credit
The Future of IgAN Care
The Future of IgAN Care
MinuteCE®
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD; An De Vriese, MD, PhD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- An De Vriese, MD, PhD
- Jörg Latus, MD
1.00 program credit
CKD-aP Uncovered Prevalence & Pathophysiology
CKD-aP Uncovered Prevalence & Pathophysiology
MinuteCE®
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Gabapentinoids: Safety Considerations and Downstream Outcomes
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®
Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit